7Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
8Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
9Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
10Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
8Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and pri- mary liver cancer worldwide [ J ]. J Hepatol, 2006, 45 ( 4 ) : 529 - 538.
9Liang M,Wang L, Ma CX,et a/.Sandwich immunoassay for hepatitis C virus non-structural 5A protein using a glassy carbon electrode modified with an Au-MoO3/chitosan nanocomposite[J].Anal Lett, 2013,46 ( 8 ) : 1241-1254.
10Martins T, Narciso-Schiavon JL, Schiavon Lde L.Epidemi- ology of hepatitis C virus infeetion[J].Rev Assoc Med Bras, 2011 ,57(1) : 107-112.
